MEOBF
Price:
$0.97
Market Cap:
$2.00B
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexle...[Read more]
Industry
Biotechnology
IPO Date
2010-10-15
Stock Exchange
OTC
Ticker
MEOBF
According to Mesoblast Limited’s latest financial reports and current stock price. The company's current ROE is -21.95%. This represents a change of 300.42% compared to the average of -5.48% of the last 4 quarters.
The mean historical ROE of Mesoblast Limited over the last ten years is -14.46%. The current -21.95% ROE has changed 51.86% with respect to the historical average. Over the past ten years (40 quarters), MEOBF's ROE was at its highest in in the June 2016 quarter at 9.14%. The ROE was at its lowest in in the June 2015 quarter at -8.81%.
Average
-14.46%
Median
-16.66%
Minimum
-19.59%
Maximum
-0.78%
Discovering the peaks and valleys of Mesoblast Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.80%
Maximum Annual ROE = -0.78%
Minimum Annual Increase = -96.01%
Minimum Annual ROE = -19.59%
Year | ROE | Change |
---|---|---|
2024 | -18.31% | 12.21% |
2023 | -16.32% | -11.21% |
2022 | -18.38% | 8.14% |
2021 | -17.00% | 19.78% |
2020 | -14.19% | -23.99% |
2019 | -18.67% | 188.82% |
2018 | -6.46% | -56.52% |
2017 | -14.86% | 1.80% |
2016 | -0.78% | -96.01% |
2015 | -19.59% | 38.34% |
The current ROE of Mesoblast Limited (MEOBF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17.67%
5-year avg
-16.84%
10-year avg
-14.46%
Mesoblast Limited’s ROE is greater than RAPT Therapeutics, Inc. (-81.47%), greater than Mesoblast Limited (-21.95%), greater than Revolution Medicines, Inc. (-37.06%), greater than Codexis, Inc. (-118.47%), greater than VYNE Therapeutics Inc. (-71.92%), less than PureTech Health plc (14.65%), greater than Pharming Group N.V. (-6.47%), less than PT Kalbe Farma Tbk. (14.88%), greater than Oi S.A. (-92.43%),
Company | ROE | Market cap |
---|---|---|
-81.47% | $193.14M | |
-21.95% | $1.98B | |
-37.06% | $7.13B | |
-118.47% | $233.62M | |
-71.92% | $19.33M | |
14.65% | $410.83M | |
-6.47% | $787.92M | |
14.88% | $4.24B | |
-92.43% | $19.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mesoblast Limited's ROE?
How is the ROE calculated for Mesoblast Limited (MEOBF)?
What is the highest ROE for Mesoblast Limited (MEOBF)?
What is the 3-year average ROE for Mesoblast Limited (MEOBF)?
What is the 5-year average ROE for Mesoblast Limited (MEOBF)?
How does the current ROE for Mesoblast Limited (MEOBF) compare to its historical average?